|
|||||
|
|
Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations |
|
| Authors: | Kato Yasuhiro Yamamoto Gou Watanabe Yasutaka Yamane Yuki Mizutani Hideaki Kurimoto Futoshi Seike Masahiro Gemma Akihiko Akagi Kiwamu Sakai Hiroshi |
| Abstract: | International Journal of Clinical Oncology - MET exon 14 skipping mutation, observed in 3–4% of non-small cell lung cancer (NSCLC), is emerging as a targetable alteration. In recent years,... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |